Pnc Financial Services Group, Inc. Nuvation Bio Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 7,000 shares of NUVB stock, worth $12,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,000
Previous 7,424
5.71%
Holding current value
$12,740
Previous $17,000
5.88%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NUVB
# of Institutions
163Shares Held
150MCall Options Held
1.2KPut Options Held
223K-
Decheng Capital LLC Menlo Park, CA26MShares$47.2 Million14.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$29.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$28.6 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$23.8 Million53.05% of portfolio
-
Octagon Capital Advisors LP New York, NY9.2MShares$16.7 Million5.46% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $395M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...